Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Investigational Oncomagnetic Device shrinks end-stage recurrent glioblastoma

Houston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third using a helmet generating a noninvasive oscillating magnetic field that the patient wore on his head while administering the therapy in his own home.

22 Jul 2021

Frailty contributes to neurocognitive decline in young adult childhood cancer survivors

Scientists at St. Jude Children's Research Hospital have found a link between post-cancer treatment frailty and neurocognitive decline in young adult childhood cancer survivors. A paper on this work was published today in the Journal of Clinical Oncology.

20 Jul 2021

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

A research team led by Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immmunotherapy - dendritic-cell (DC) treatment vaccines.

20 Jul 2021

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).

20 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

Study elucidates the role of two isoforms of KRAS oncogenes

KRAS was one of the first oncogenes to be identified, a few decades ago. It is among the most common drivers of cancer and its mutations can be detected in around 25 per cent of human tumors.

19 Jul 2021

T cells can be engineered to fight tumors without succumbing to exhaustion

Fighting a tumor is a marathon, not a sprint. For cancer-fighting T cells, the race is sometimes just too long, and the T cells quit fighting. Researchers even have a name for this phenomenon: T cell exhaustion.

19 Jul 2021

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Wake Forest researchers and clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest cancers affecting only 1 in 100,000 people.

19 Jul 2021

Tissue-specific genetic interactions drive different types of cancer development

Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.

19 Jul 2021

$50,000 grant to help explore the use of turmeric for reducing joint pain in breast cancer patients

UC Davis Comprehensive Cancer Center received a $50,000 grant from the Safeway Foundation to explore the use of the South Asian spice Turmeric as a way of reducing joint pain in breast cancer patients being treated with anti-estrogen drugs.

16 Jul 2021

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

The investigational therapeutic ficlatuzumab in combination with chemotherapy showed signs of clinical efficacy in patients with relapsed/refractory acute myeloid leukemia.

16 Jul 2021

Antihypertension drug may benefit patients with neurofibromatosis type 2

New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.

15 Jul 2021

Researchers study the role of subnuclear NSrp70 in T cell-mediated adaptive immunity

T cells are components of the body’s immune system. The ability of T cells to recognize diverse pathogens and mount a defense against them stems from the way proteins are spliced during their development and maturation.

15 Jul 2021

New online educational program on shared decision making in lung cancer screening

The American College of Chest Physicians and Thomas Jefferson University are launching a free online educational program titled "Shared Decision Making in Lung Cancer Screening" to assist healthcare workers with identifying eligible patients for lung cancer screening and helping patients make a well-informed decision about whether to be screened.

14 Jul 2021

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

A phase II study led by researchers from The University of Texas MD Anderson Cancer Center found that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% objective response rate in patients with advanced malignant peritoneal mesothelioma, a rare cancer in the lining of the abdomen.

14 Jul 2021

Lott donates $600,000 to the Zero Childhood Cancer Program

Today we'd like to say a big thank you to the Lott for their generous donation of $600,000 to the Zero Childhood Cancer Program.

14 Jul 2021

New study finds an association between alcohol use and higher risk of several cancers

A new study from the World Health Organization's International Agency for Research on Cancer (IARC), published in the journal Lancet Oncology, has found an association between alcohol and a substantially higher risk of several forms of cancer, including breast, colon, and oral cancers.

14 Jul 2021

WVU researcher-led effort ensures accuracy of data that dictates cancer patient's radiation therapy

Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks safely, radiation oncologists treating a variety of cancers can use new guidelines developed by a West Virginia University researcher to reduce mistakes in data transfer and more safely treat their patients.

13 Jul 2021

Early anticlotting therapy offers benefits for moderately ill patients with Covid-19

COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death.

13 Jul 2021

Static magnetic field from MRI scanner decreases blood-brain barrier opening volume

MRI-guided focused ultrasound combined with microbubbles can open the blood-brain barrier (BBB) and allow therapeutic drugs to reach the diseased brain location under the guidance of MRI.

13 Jul 2021

Oncology News and Research

Further Reading

Investigational Oncomagnetic Device shrinks end-stage recurrent glioblastoma

Frailty contributes to neurocognitive decline in young adult childhood cancer survivors

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Study elucidates the role of two isoforms of KRAS oncogenes

T cells can be engineered to fight tumors without succumbing to exhaustion

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Tissue-specific genetic interactions drive different types of cancer development

$50,000 grant to help explore the use of turmeric for reducing joint pain in breast cancer patients

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Antihypertension drug may benefit patients with neurofibromatosis type 2

Researchers study the role of subnuclear NSrp70 in T cell-mediated adaptive immunity

New online educational program on shared decision making in lung cancer screening

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

Lott donates $600,000 to the Zero Childhood Cancer Program

New study finds an association between alcohol use and higher risk of several cancers

WVU researcher-led effort ensures accuracy of data that dictates cancer patient's radiation therapy

Early anticlotting therapy offers benefits for moderately ill patients with Covid-19

Static magnetic field from MRI scanner decreases blood-brain barrier opening volume

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News